{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:06Z","timestamp":1786120386617,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/ico.0b013e31823f7857","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T04:47:32Z","timestamp":1329194852000},"page":"817-819","source":"Crossref","is-referenced-by-count":12,"title":["Expression of SIRT1 in Ocular Surface Squamous Neoplasia"],"prefix":"10.1097","volume":"31","author":[{"given":"Luiz Filipe de A.","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno F.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia V.","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 J.","family":"Mansure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre N.","family":"Odashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Antecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique F.","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel N.","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210204","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/biot.200700087","article-title":". Function of the SIRT1 protein deacetylase in cancer.","volume":"2","author":"Stunkel","year":"2007","journal-title":"Biotechnol J"},{"key":"R2-19-20210204","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5483\/BMBRep.2008.41.11.751","article-title":"SIRT1: roles in aging and cancer.","volume":"41","author":"Kim","year":"2008","journal-title":"BMB Rep"},{"key":"R3-19-20210204","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/0008-5472.CAN-07-0085","article-title":". SIRT1 is significantly elevated in mouse and human prostate cancer.","volume":"67","author":"Huffman","year":"2007","journal-title":"Cancer Res"},{"key":"R4-19-20210204","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","article-title":". Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.","volume":"19","author":"Bradbury","year":"2005","journal-title":"Leukemia"},{"key":"R5-19-20210204","first-page":"341","article-title":"SIRT1: tumor promoter or tumor suppressor Med Hypotheses.","volume":"67","author":"Lim","year":"2006","journal-title":""},{"key":"R6-19-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10792-008-9257-8","article-title":". Intraepithelial and invasive squamous neoplasms of the conjunctiva in Ibadan, Nigeria: a clinicopathological study of 46 cases.","volume":"29","author":"Ogun","year":"2009","journal-title":"Int Ophthalmol"},{"key":"R7-19-20210204","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia.","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"R8-19-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ohc.2004.08.001","article-title":"Ocular surface squamous neoplasia.","volume":"18","author":"Peer","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"R9-19-20210204","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue.","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"R10-19-20210204","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":". Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"R11-19-20210204","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(04)00126-6","article-title":". Mammalian SIRT1 represses forkhead transcription factors.","volume":"116","author":"Motta","year":"2004","journal-title":"Cell"},{"key":"R12-19-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-006-0725-6","article-title":". Strong expression of a longevity-related protein, SIRT1, in Bowens disease.","volume":"299","author":"Hida","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"R13-19-20210204","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archopht.120.5.554","article-title":"Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia.","volume":"120","author":"Mahomed","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R14-19-20210204","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/1535-7163.MCT-09-1000","article-title":". The histone deacetylase inhibitor MGCD0103 induces apoptosis in B-cell chronic lymphocytic leukemia cells through a mitochondria-mediated caspase activation cascade.","volume":"9","author":"El-Khoury","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"R15-19-20210204","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1535-7163.MCT-07-2026","article-title":". MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.","volume":"7","author":"Fournel","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"R16-19-20210204","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy.","volume":"27","author":"Lane","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201207000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:39:40Z","timestamp":1786048780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201207000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31823f7857","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}